$Rexahn Pharmaceuticals, Inc.(RNN)$ 8-K - Current report Filed: 2018-08-21 AccNo: 0001140361-18-036732 Size: 45 KBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接